Fresenius Medical Care AG & Co. KGaA (FMS)
$21.08-0.61%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $11.3B
- Beta
- 0.72
- Div yield
- 4.10%
- P/E (TTM)
- 11.42
- Short % float
- 0.58%
- Days to cover
- 3.3
- SI change
- +3.0%
- 1W
- -5.98%
- 1M
- -7.79%
- vs SPY 1W
- -5.84%
- vs SPY 1M
- -10.29%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 47
- VALUE
- 49
- GROWTH
- 48
- GARP
- 23
- TYPE
- Dividend Compounder
Composite of Value · Growth · GARP
ROIC4.3%
REV YoY-
ROE7.2%
EPS YoY-
ROA3.0%
GROSS26
OP11
NET5
[VALUATION]
P/E TTM11.42
P/E FWD11.07
SECTOR PE20.34
INDUSTRY PE30.33
P/B0.81
P/FCF-
EV/EBITDA5.63
EV/EBIT-
PEG2.59
FCF YIELD-
RISK
INT COV-
D/E87.31
ALTMAN Z-
CURR RATIO1.07
ND/EBITDA-
BETA0.72
Company news
FAQ
- What is LOPJLB’s current signal on FMS?
- LOPJLB’s latest quantitative signal on Fresenius Medical Care AG & Co. KGaA (FMS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is FMS in?
- Fresenius Medical Care AG & Co. KGaA (FMS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Fresenius Medical Care AG & Co. KGaA (FMS) do?
- Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment,…